“…The same can be said about the role of receptors for μand κ-opioid peptides and cannabinoids (CB1), which, similar to substance P (Yang et al, 2014;Lee et al, 2018), also produce interesting effects via the dorsal diencephalic trajectory (Gardon et al, 2014;Boulos et al, 2020;Simmons et al, 2020;Vickstrom et al, 2021;Zapata & Lupica, 2021). We have recently obtained evidence that serum levels of β-endorphin, an endogenous μand δ-opioid receptor agonist (Terenius, 2000), are lower in patients with alcohol use disorder, particularly in those with depressive co-morbidity and correlate with physical aggression (Roschina et al, 2021). As some fibres from the arcuate nucleus, expressing the precursor protein of β-endorphin, pass through the stria medullaris to the medial habenula (Sim & Joseph, 1991) and the serum levels may express the activity of intracerebral release, it is tempting to speculate that this might have something to do with changes in μ-opioid receptors activation in the medial habenula.…”